Methotrexate therapy as a promising long-term treatment approach for immune-mediated adverse reactions of tofersen in SOD1-ALS: a case report

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Maximilian Vidovic - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Hanna Sophie Lapp - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Isabelle Dittes - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Nicolai Leuchten - , Department of Internal Medicine III, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)
Martin Aringer - , Department of Internal Medicine III, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)
Claudia Günther - , Department of Dermatology, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)
René Günther - , Department of Neurology, University Center for Autoimmune and Rheumatic Diseases (UCARE), German Center for Neurodegenerative Diseases (DZNE) - Partner Site Dresden (Author)

Adverse reactions, Autoimmune, Immune-mediated, Immunosuppression, Methotrexate, Myelitis, SOD1-ALS, Tofersen